Sanchez-Castellano et al. (2020) showed that TNF-α was lower in sarcopenic than in non-sarcopenic participants (7.9 ± 6.2 vs. 8.3 ± 5.8 pg/mL; p < 0.05), whereas the results of Bermejo-Bescós et al. (2020) highlighted that IL-6 baseline levels were significantly higher in the group of participants who died in the year after their hip fracture (p = 0.026); however, this was independent of patient sarcopenia status [19,22]. This evidence concerns the gene TNF and sarcopenia.